CRISPR-Cas9 is heralded as a revolutionary gene editing technology that is regularly hitting the headlines for both its scientific promise and fiercely fought patent wars. Head over to our Bristows Competition and EU team blog, The CLIP Board to find out more about competition law issues which surround the growing trend for the creation of patent pools in the life sciences sector.